Characterizing the lipid and metabolite changes associated with placental function and pregnancy complications using ion mobility spectrometry-mass spectrometry and mass spectrometry imaging.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28392013)

Published in Placenta on March 29, 2017

Authors

Kristin E Burnum-Johnson1, Erin S Baker2, Thomas O Metz3

Author Affiliations

1: Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA.
2: Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. Electronic address: erin.baker@pnnl.gov.
3: Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, USA. Electronic address: thomas.metz@pnnl.gov.

Articles cited by this

METLIN: a metabolite mass spectral database. Ther Drug Monit (2005) 10.15

MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom (2010) 6.16

Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem (2006) 4.36

Ion mobility-mass spectrometry. J Mass Spectrom (2008) 2.91

Mapping the human plasma proteome by SCX-LC-IMS-MS. J Am Soc Mass Spectrom (2007) 1.94

Ion mobility spectrometry-mass spectrometry performance using electrodynamic ion funnels and elevated drift gas pressures. J Am Soc Mass Spectrom (2007) 1.93

Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag (2011) 1.86

Separation of isomeric peptides using electrospray ionization/high-resolution ion mobility spectrometry. Anal Chem (2000) 1.64

Uterine-specific p53 deficiency confers premature uterine senescence and promotes preterm birth in mice. J Clin Invest (2010) 1.64

Spatial and temporal alterations of phospholipids determined by mass spectrometry during mouse embryo implantation. J Lipid Res (2009) 1.58

Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension (2010) 1.55

An LC-IMS-MS platform providing increased dynamic range for high-throughput proteomic studies. J Proteome Res (2010) 1.37

Searching molecular structure databases with tandem mass spectra using CSI:FingerID. Proc Natl Acad Sci U S A (2015) 1.10

Developing liquid chromatography ion mobility mass spectometry techniques. Expert Rev Proteomics (2005) 1.08

Ion mobility-mass spectrometry: time-dispersive instrumentation. Anal Chem (2015) 1.04

Combinatory approaches prevent preterm birth profoundly exacerbated by gene-environment interactions. J Clin Invest (2013) 1.02

Changes in the metabolic footprint of placental explant-conditioned culture medium identifies metabolic disturbances related to hypoxia and pre-eclampsia. Placenta (2009) 0.95

High-speed tandem mass spectrometric in situ imaging by nanospray desorption electrospray ionization mass spectrometry. Anal Chem (2013) 0.94

Isomer separation and gas-phase configurations of organoruthenium anticancer complexes: ion mobility mass spectrometry and modeling. J Am Soc Mass Spectrom (2009) 0.93

Metabolomic biomarkers in serum and urine in women with preeclampsia. PLoS One (2014) 0.92

Uncovering biologically significant lipid isomers with liquid chromatography, ion mobility spectrometry and mass spectrometry. Analyst (2016) 0.92

Strategies to characterize polar organic contamination in wastewater: exploring the capability of high resolution mass spectrometry. Environ Sci Technol (2014) 0.89

A metabolomic approach identifies differences in maternal serum in third trimester pregnancies that end in poor perinatal outcome. Reprod Sci (2012) 0.88

Detecting and removing data artifacts in Hadamard transform ion mobility-mass spectrometry measurements. J Am Soc Mass Spectrom (2014) 0.88

First-trimester prediction of preeclampsia using metabolomic biomarkers: a discovery phase study. Prenat Diagn (2011) 0.88

Changes in the metabolic footprint of placental explant-conditioned medium cultured in different oxygen tensions from placentas of small for gestational age and normal pregnancies. Placenta (2010) 0.88

Uterine deletion of Trp53 compromises antioxidant responses in the mouse decidua. Endocrinology (2012) 0.84

Diastereomer assignment of an olefin-linked bis-paracyclophane by ion mobility mass spectrometry. J Am Chem Soc (2004) 0.84

Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different oxygen tensions reveals novel redox biomarkers. Placenta (2008) 0.83

MetFrag relaunched: incorporating strategies beyond in silico fragmentation. J Cheminform (2016) 0.82

Three-dimensional imaging of lipids and metabolites in tissues by nanospray desorption electrospray ionization mass spectrometry. Anal Bioanal Chem (2014) 0.82

Lipidomic assessment of plasma and placenta of women with early-onset preeclampsia. PLoS One (2014) 0.81

Ion Mobility Separations of Isomers based upon Long Path Length Structures for Lossless Ion Manipulations Combined with Mass Spectrometry. ChemistrySelect (2016) 0.81

Comparison of phospholipid molecular species between terminal and stem villi of human term placenta by imaging mass spectrometry. Placenta (2010) 0.80

Trp53 deficient mice predisposed to preterm birth display region-specific lipid alterations at the embryo implantation site. Sci Rep (2016) 0.77

Maternal Early Pregnancy Serum Metabolomics Profile and Abnormal Vaginal Bleeding as Predictors of Placental Abruption: A Prospective Study. PLoS One (2016) 0.77

Lipid fingerprinting in women with early-onset preeclampsia: a first look. Clin Biochem (2012) 0.77

Contaminant screening of wastewater with HPLC-IM-qTOF-MS and LC+LC-IM-qTOF-MS using a CCS database. Anal Bioanal Chem (2016) 0.77

Novel "omics" approach for study of low-abundance, low-molecular-weight components of a complex biological tissue: regional differences between chorionic and basal plates of the human placenta. Anal Bioanal Chem (2015) 0.77

Decrease in Sphingomyelin (d18:1/16:0) in Stem Villi and Phosphatidylcholine (16:0/20:4) in Terminal Villi of Human Term Placentas with Pathohistological Maternal Malperfusion. PLoS One (2015) 0.75

Simultaneous Proteomic Discovery and Targeted Monitoring using Liquid Chromatography, Ion Mobility Spectrometry, and Mass Spectrometry. Mol Cell Proteomics (2016) 0.75